Bone Density Test (DXA): What It Is and How to Read Results

The DXA scan stands as the cornerstone of osteoporosis evaluation, providing the objective measurement that transforms vague concerns about bone health into specific actionable information. Before this test, many patients have no clear understanding of their bone density status. Subtle signs of osteoporosis can suggest possible disease, but they cannot quantify it. After the test, patients have specific numbers that classify their bone density and inform decisions about further evaluation, lifestyle modifications, and possible treatment. The test does not just identify osteoporosis but also detects the earlier stage of low bone density (osteopenia) that affects substantial numbers of patients before progression to osteoporosis.

The technology underlying DXA scanning involves dual-energy X-ray absorptiometry, which uses two X-ray beams of different energies to distinguish bone from soft tissue. The differential absorption allows precise measurement of bone mineral content. The radiation exposure is very low, substantially less than a standard chest X-ray and far less than a CT scan. The procedure is quick, painless, and well-tolerated. The combination of accuracy, safety, and patient comfort makes DXA scanning the standard tool for bone density assessment.

The interpretation of DXA results involves both T-scores (comparing bone density to young healthy adults) and Z-scores (comparing to age-matched peers). The scores at multiple body sites including the spine and hip support comprehensive assessment. Specific T-score ranges define osteoporosis (-2.5 or lower), osteopenia (between -1.0 and -2.5), and normal bone density (above -1.0). The classifications guide clinical decisions but represent one element of comprehensive risk assessment that also incorporates clinical factors through tools like FRAX.

The clinical importance of DXA scanning reflects both diagnostic and management roles. The initial scan establishes baseline bone density status. Follow-up scans track changes over time. Treatment response can be assessed through changes between scans. Various special situations including evaluation of patients with risk factors, monitoring of bone-affecting medications, and various others all benefit from DXA assessment. The combination of these various roles makes DXA a frequently used and important diagnostic tool.

This article examines DXA scanning comprehensively. It explains what DXA is and how it works, identifies what the scan measures, discusses interpretation of results including T-scores and Z-scores, addresses practical aspects of the procedure, and frames the broader context of using DXA results for clinical decisions. The understanding supports informed engagement with this important diagnostic tool.

For more on related considerations, see Osteoporosis: Causes, Symptoms, Diagnosis, Fracture Risk, and Treatment (Complete Guide).

⸻

What DXA Is and How It Works

The technology underlying DXA scanning provides the foundation for understanding the test.

Definition

DXA stands for dual-energy X-ray absorptiometry. The technique uses two X-ray beams of different energies to measure bone mineral content. The dual-energy approach allows the technology to distinguish bone from surrounding soft tissue with substantial precision.

How the Technology Works

The scanner emits two X-ray beams that pass through the body part being scanned. Different tissues absorb X-rays differently based on their density and composition. The detector measures how much of each beam passes through. The differential absorption between the two energies allows precise calculation of bone mineral density (BMD).

Sites Typically Scanned

DXA scans typically include several body sites:

• Lumbar spine (typically L1-L4 vertebrae).
• Total hip.
• Femoral neck.
• Sometimes others including forearm, total body.

The combination provides comprehensive assessment.

Radiation Exposure

A typical DXA scan delivers approximately 1 to 5 microsieverts of radiation. A chest X-ray delivers approximately 100 microsieverts. A CT scan of the abdomen delivers approximately 10,000 microsieverts. The very low radiation makes DXA appropriate for routine use including periodic monitoring.

Other Imaging Approaches

While DXA is the standard, other approaches exist: Quantitative CT (QCT) provides volumetric bone density assessment. Peripheral DXA scans wrist or heel. Quantitative ultrasound assesses bone properties. DXA at central sites (spine and hip) remains the standard for diagnosis and monitoring.

For more on related considerations, see Symptoms of Osteoporosis: Early Signs You Should Not Ignore.

⸻

What DXA Measures

Bone Mineral Density (BMD)

The primary measurement is bone mineral density (BMD), expressed in grams per square centimeter (g/cm²). The measurement quantifies the amount of bone mineral in a given area. Higher BMD indicates more bone mineral, while lower BMD indicates less.

T-Scores and Z-Scores

The BMD is converted to standardized scores for clinical use. T-scores compare BMD to the average peak BMD of young healthy adults of the same sex. Z-scores compare BMD to the average BMD of others of the same age, sex, and ethnicity.

Multiple Site Reporting

Reports typically include results from multiple sites. Different sites can show different patterns. The lowest score among the standard sites typically guides clinical classification.

For more on score interpretation, see T-Score and FRAX: How Fracture Risk Is Calculated.

What DXA Does Not Measure

DXA has limitations: It measures areal density (per square centimeter) rather than volumetric density. It does not directly measure bone quality or bone microarchitecture. Various artifacts can affect specific site measurements.

⸻

Interpreting Results

Standard Categories

Standard categories based on T-scores include:

• Normal: T-score above -1.0 (BMD within 1 standard deviation of young adult mean).
• Osteopenia (low bone mass): T-score between -1.0 and -2.5.
• Osteoporosis: T-score of -2.5 or lower.
• Severe (established) osteoporosis: T-score of -2.5 or lower with one or more fragility fractures.

Site-Specific Considerations

The lowest T-score among the standard sites typically guides classification. Higher spine BMD with lower hip BMD can suggest osteoarthritis affecting spine measurements. Lower spine BMD with normal hip BMD can occur in some clinical situations.

Z-Scores in Specific Populations

Z-scores are typically used for premenopausal women, men under 50, and children. Z-scores below -2.0 in these populations suggest below-expected BMD warranting evaluation for secondary causes.

Vertebral Fractures

Patients with vertebral fractures essentially have osteoporosis regardless of T-score. Some DXA scanners include vertebral fracture assessment (VFA) capability that can identify fractures during the scan.

For more on causes, see What Causes Osteoporosis? Risk Factors Explained.

⸻

Who Should Have DXA Testing

Postmenopausal Women

Recommendations typically include all women age 65 or older, and postmenopausal women under 65 with risk factors (including various medical conditions, medications, family history, low body weight, and various others).

Men

Recommendations for men generally include all men age 70 or older, men 50 to 69 with risk factors, and men of any age with conditions or medications affecting bone health.

Patients With Fragility Fractures

Patients with fragility fractures of any age warrant DXA testing as part of evaluation.

Patients Starting Bone-Affecting Medications

Patients starting medications affecting bone health (particularly long-term corticosteroids) warrant baseline DXA before treatment.

Monitoring of Treatment

Monitoring of osteoporosis treatment typically involves periodic DXA testing. Initial follow-up scans are typically 1 to 2 years after starting treatment. Subsequent scans are typically every 2 to 3 years if stable.

For more on differences, see Osteoporosis in Women vs Men: Key Differences.

⸻

What to Expect During the Procedure

Pre-Procedure Preparation

Patients should avoid taking calcium supplements for 24 hours before the scan, wear comfortable clothing without metal elements, inform the technician of any recent contrast or barium studies, and avoid the scan during pregnancy if possible (though radiation is very low).

The Scan

The patient lies on a padded scanning table. The scanner moves slowly over the body parts being scanned. The patient must remain still during the scan but does not need to hold still in unusual positions. The procedure takes approximately 10 to 30 minutes total and is painless — there are no needles, contrast, or sedation involved.

After the Procedure

Normal activities resume immediately with no restrictions or recovery period. Results typically take a few days to be available.

For more on prevention, see How to Prevent Osteoporosis: Lifestyle and Nutrition.

⸻

Frequency of Testing

Patients With Normal Bone Density

Patients with normal bone density and limited risk factors may not need repeat testing for several years (often 5 to 10 years or more).

Patients With Osteopenia

Patients with osteopenia (low bone mass) typically undergo follow-up in 2 to 5 years depending on risk factors and specific findings.

Patients With Osteoporosis

Patients with osteoporosis on treatment typically undergo follow-up in 1 to 2 years initially, then every 2 to 3 years if stable.

Significant Changes

Significant changes between scans (typically requiring more than 0.5 standard deviation change in T-score) suggest meaningful changes warranting consideration of management modifications.

For more on FRAX assessment, see T-Score and FRAX: How Fracture Risk Is Calculated.

⸻

What DXA Cannot Tell You

Bone Quality

DXA measures bone density but does not directly assess bone quality. Bone quality includes microscopic structure, bone turnover, and various other factors that affect bone strength beyond just density. Some patients have substantial fracture risk despite reasonable bone density due to bone quality issues.

Cause of Bone Loss

DXA does not identify the cause of bone loss — it just measures the result. Comprehensive evaluation including clinical history, physical examination, and laboratory testing addresses underlying causes.

For more on secondary causes, see Secondary Osteoporosis: Causes and When to Suspect It.

Various Artifacts

Various artifacts can affect DXA measurements: calcifications in the spine, aortic calcification, previous spinal surgery, and various other factors. The artifacts can produce falsely elevated or decreased measurements at affected sites.

⸻

Comparison With Other Approaches

Quantitative CT (QCT)

Quantitative CT provides volumetric bone density rather than the areal density of DXA. Advantages include volumetric measurement, separate assessment of cortical and trabecular bone, and less susceptibility to some DXA artifacts. Limitations include higher radiation exposure, less standardization, and higher cost.

Peripheral DXA and Quantitative Ultrasound

Peripheral DXA scans wrist or heel and is sometimes used for screening or where central DXA is unavailable. Quantitative ultrasound assesses bone properties using sound waves, is radiation-free and portable, but generally cannot substitute for DXA in definitive diagnosis.

TBS (Trabecular Bone Score)

Trabecular bone score is sometimes calculated from DXA scans to assess bone microarchitecture, providing additional information beyond just density.

For more on related considerations, see Most Commonly Misdiagnosed Conditions.

⸻

Common Misconceptions

• DXA provides complete bone health assessment — DXA measures density but not all aspects of bone health.
• Normal DXA means no fracture risk — Various factors beyond density affect fracture risk.
• Abnormal DXA means imminent fracture — Abnormal DXA indicates elevated risk but not certain fracture.
• DXA radiation is substantial — DXA radiation is very low, far less than typical X-rays.
• DXA is painful — DXA is painless and noninvasive.
• DXA measures calcium — DXA measures bone mineral content, not specifically calcium intake or status.
• DXA should be repeated frequently — Repeat scans at appropriate intervals (typically 1 to several years) provide useful information; more frequent scans are not typically helpful.

⸻

Special Patient Populations

Postmenopausal women are the population for which DXA is best validated. Men over 50 also benefit from DXA assessment. Premenopausal women and men under 50 require Z-score interpretation rather than T-scores. Children and adolescents require pediatric-specific reference ranges. Patients with very high BMI may have measurement challenges. Patients with spinal conditions including significant arthritis, scoliosis, or previous surgery may have measurement artifacts at the spine — hip measurements may be more reliable. Patients with hip conditions including previous hip replacement may have measurement issues at the affected hip, and the other hip can be used.

For more on causes, see What Causes Osteoporosis? Risk Factors Explained.

⸻

When to See a Specialist

Primary care physicians manage many patients with osteoporosis evaluation. Endocrinologists evaluate complex cases. Rheumatologists and gynecologists (for postmenopausal women) may address bone health. Radiologists provide expertise in DXA interpretation. For complex situations including unusual results, multiple risk factors, or various other concerns, evaluation at major medical centers with comprehensive bone health programs provides specialized expertise.

⸻

Conclusion

DXA scanning is the cornerstone of osteoporosis evaluation. The dual-energy X-ray absorptiometry technique provides accurate, safe, and accessible measurement of bone density.

The technology uses two X-ray beams of different energies to distinguish bone from soft tissue and precisely measure bone mineral content. Radiation exposure is very low, far less than standard X-rays. DXA measures bone mineral density (BMD) at multiple sites including lumbar spine, total hip, femoral neck, and sometimes others. The BMD is converted to T-scores (comparing to young healthy adults) and Z-scores (comparing to age-matched peers) for clinical use.

Standard categories based on T-scores include normal (above -1.0), osteopenia (-1.0 to -2.5), osteoporosis (-2.5 or lower), and severe osteoporosis (-2.5 or lower with fragility fractures). Z-scores below -2.0 in younger populations suggest below-expected BMD warranting secondary cause evaluation.

Recommendations for DXA testing include all postmenopausal women age 65 or older, postmenopausal women under 65 with risk factors, men age 70 or older or with risk factors, patients with fragility fractures, patients starting bone-affecting medications, and patients with conditions affecting bone.

The procedure is straightforward, painless, takes 10 to 30 minutes, and requires no recovery. Frequency of follow-up depends on initial findings and risk factors. DXA limitations include not directly assessing bone quality, not identifying the cause of bone loss, not predicting future fractures definitively, various artifacts, and limitations in specific populations.

Using DXA results effectively involves discussing results with healthcare providers, asking specific questions, tracking over time, combining with other information, and following through on recommendations. The combination of DXA results with comprehensive clinical assessment supports effective bone health management.

⸻

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Individuals should consult a qualified healthcare provider for diagnosis and treatment.